This Drug Stock Could Help Traders Make 127% in Short Term Gains
Drug stocks are often volatile, especially when they are in China. GlobeNewswire recently reported, “Zai Lab Limited (Nasdaq: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the China National Medical Products Administration (NMPA) approved the New Drug Application (NDA) for ZEJULA (niraparib),...